Visit the Vivo Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
ABCann Announces Resignation of Founding Director Ken Clement
NAPANEE, Ontario, March 16, 2018 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (Frankfurt:23Q) (OTC:ABCCF) (“ABcann” or the “Company”) announced that Ken Clement, ABcann’s founder and director, has resigned from the Board of Directors.
On behalf of the Board, we thank Ken for his vision in starting the company and growing it from a start-up organization into a well-funded publicly-traded licensed producer with a bright future. We wish Ken well in his future endeavours.
Paul Lucas, ABcann’s Chair
ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centred on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products.
The Company is expanding its cultivation capacity and pursuing partnerships and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel.
The most reliable, fact-based information on Vivo Cannabis found only on its Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.